12th May 2015 Content supplied by: Cherwell Laboratories
Cherwell appoints Operations Director to Reinforce Manufacturing Expertise
Cherwell Laboratories, specialists in cleanroom microbiology solutions, are pleased to announce the appointment of Martyn Young as Operations Director. Martyn’s appointment follows a period of growth for Cherwell Laboratories and marks their commitment to further strengthening the business, whilst maintaining the traditional values which have contributed to the Company’s success.
Having joined the Board at Cherwell, Martyn will work alongside Managing Director, Andy Whittard, developing future strategic plans for the business. Andy commented, “We are delighted to welcome Martyn to Cherwell Laboratories to focus on future operational improvements which retain our flexibility and responsiveness, and contribute to our continued growth.” He added, “Martyn brings a wealth of experience and knowledge of operations within the medical device industry having previously worked in senior roles at Owen Mumford, and more recently Oval Medical.”
Prior to joining Cherwell, Martyn’s career has been predominantly in manufacturing. He initially specialised in Quality and Quality Management before broadening his managerial and technical skills by moving into Production Process Engineering, followed by Production Management and then General Management.
Most recently, Martyn has been actively engaged in the development of products and processes suitable for deployment in aseptic liquid drug filling environments. Here he worked with equipment suppliers, drug filling companies, environmental management, regulatory authorities, sterilising method providers, as well as the pharmaceutical clients themselves.
Martyn has also previously led organisations in the development, manufacture and supply of drug device combination products for parenteral drug delivery. The clients for these products are all world class pharmaceutical companies who are active in the development, manufacture and supply of drugs for injection in the treatment of various conditions.
Commenting on his new role, Martyn Young said, “I am excited to be part of Cherwell’s ongoing growth plans and to bring new insights for operational improvements to ensure we continue to deliver the flexibility and responsiveness that our customers know and expect.”
Martyn’s broad experience, technical expertise and industry knowledge gained will further enhance Cherwell’s position as a leading supplier of prepared microbiological media and other cleanroom microbiology solutions for pharmaceutical and related industries.
For more information about Cherwell Laboratories, please visit www.cherwell-labs.co.uk or follow @CherwellLabs on Twitter.
Date Published: 12th May 2015
Source article link: View
Redipor® Prepared Media Price List
Reducing Risk from Bacterial Endospores